NOVEL FUNCTIONS OF THE NEURAL CELL ADHESION MOLECULE L1 AND IMPLICATIONS FOR THE PATHOGENESIS OF L1 SYNDROME
- 3 Years 2004/2007
- 182.427€ Total Award
L1 is membrane protein that plays a crucial role in the development of the central nervous system. Mutations of the L1 gene induce various neurological defects known as the L1 syndrome or the CRASH syndrome.Our research aims at identifying novel functions of L1, based on data previosly published by our group and on our preliminary results, which suggest a functional interaction between L1 and a family of membrane receptors (FGFRs) able to transmit various signals inside the cell. Our experimental approach will have relevant implications in the characterization of the physiological role of L1 and of the L1/FGFR complex. Moreover, our studies will enable us to verify whether the pathogenetico role of L1 mutations is due, at least in part, to an altered molecular "communication" between L1 and the FGFRs. Therefore, the results of our research might open novel therapeutic oppotunities aimed at preventing or treating the neurological defects associated with the L1 syndrome.
Scientific Publications
- 2011 EMBO MOLECULAR MEDICINE
The adhesion molecule NCAM promotes ovarian cancer progression via FGFR signalling
- 2009 JOURNAL OF EXPERIMENTAL MEDICINE
The adhesion molecule L1 regulates transendothelial migration and trafficking of dendritic cells
- 2014 JOURNAL OF CLINICAL INVESTIGATION
Endothelial deficiency of L1 reduces tumor angiogenesis and promotes vessel normalization
- 2009 JOURNAL OF CELL BIOLOGY
The binding of NCAM to FGFR1 induces a specific cellular response mediated by receptor trafficking
- 2011 NATURE REVIEWS MOLECULAR CELL BIOLOGY
Adhesion molecule signalling: not always a sticky business
- 2009 SEMINARS IN CANCER BIOLOGY
The functional role of cell adhesion molecules in tumor angiogenesis
- 2008 CANCER RESEARCH
The differential role of L1 in ovarian carcinoma and normal ovarian surface epithelium
- 2010 INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
Immunoglobulin-like cell adhesion molecules: Novel signaling players in epithelial ovarian cancer